Cargando…

Soluble phospho-tau from Alzheimer’s disease hippocampus drives microglial degeneration

The role of microglial cells in the development and progression of Alzheimer’s disease (AD) has not been elucidated. Here, we demonstrated the existence of a weak microglial response in human AD hippocampus which is in contrast to the massive microglial activation observed in APP-based models. Most...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanchez-Mejias, Elisabeth, Navarro, Victoria, Jimenez, Sebastian, Sanchez-Mico, Maria, Sanchez-Varo, Raquel, Nuñez-Diaz, Cristina, Trujillo-Estrada, Laura, Davila, Jose Carlos, Vizuete, Marisa, Gutierrez, Antonia, Vitorica, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5106501/
https://www.ncbi.nlm.nih.gov/pubmed/27743026
http://dx.doi.org/10.1007/s00401-016-1630-5
_version_ 1782467053741932544
author Sanchez-Mejias, Elisabeth
Navarro, Victoria
Jimenez, Sebastian
Sanchez-Mico, Maria
Sanchez-Varo, Raquel
Nuñez-Diaz, Cristina
Trujillo-Estrada, Laura
Davila, Jose Carlos
Vizuete, Marisa
Gutierrez, Antonia
Vitorica, Javier
author_facet Sanchez-Mejias, Elisabeth
Navarro, Victoria
Jimenez, Sebastian
Sanchez-Mico, Maria
Sanchez-Varo, Raquel
Nuñez-Diaz, Cristina
Trujillo-Estrada, Laura
Davila, Jose Carlos
Vizuete, Marisa
Gutierrez, Antonia
Vitorica, Javier
author_sort Sanchez-Mejias, Elisabeth
collection PubMed
description The role of microglial cells in the development and progression of Alzheimer’s disease (AD) has not been elucidated. Here, we demonstrated the existence of a weak microglial response in human AD hippocampus which is in contrast to the massive microglial activation observed in APP-based models. Most importantly, microglial cells displayed a prominent degenerative profile (dentate gyrus > CA3 > CA1 > parahippocampal gyrus), including fragmented and dystrophic processes with spheroids, a reduced numerical density, and a significant decrease in the area of surveillance (“microglial domain”). Consequently, there was a substantial decline in the area covered by microglia which may compromise immune protection and, therefore, neuronal survival. In vitro experiments demonstrated that soluble fractions (extracellular/cytosolic) from AD hippocampi were toxic for microglial cells. This toxicity was abolished by AT8 and/or AT100 immunodepletion, validating that soluble phospho-tau was the toxic agent. These results were reproduced using soluble fractions from phospho-tau-positive Thy-tau22 hippocampi. Cultured microglial cells were not viable following phagocytosis of SH-SY5Y cells expressing soluble intracellular phospho-tau. Because the phagocytic capacity of microglial cells is highly induced by apoptotic signals in the affected neurons, we postulate that accumulation of intraneuronal soluble phospho-tau might trigger microglial degeneration in the AD hippocampus. This microglial vulnerability in AD pathology provides new insights into the immunological mechanisms underlying the disease progression and highlights the need to improve or develop new animal models, as the current models do not mimic the microglial pathology observed in the hippocampus of AD patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00401-016-1630-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5106501
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-51065012016-11-25 Soluble phospho-tau from Alzheimer’s disease hippocampus drives microglial degeneration Sanchez-Mejias, Elisabeth Navarro, Victoria Jimenez, Sebastian Sanchez-Mico, Maria Sanchez-Varo, Raquel Nuñez-Diaz, Cristina Trujillo-Estrada, Laura Davila, Jose Carlos Vizuete, Marisa Gutierrez, Antonia Vitorica, Javier Acta Neuropathol Original Paper The role of microglial cells in the development and progression of Alzheimer’s disease (AD) has not been elucidated. Here, we demonstrated the existence of a weak microglial response in human AD hippocampus which is in contrast to the massive microglial activation observed in APP-based models. Most importantly, microglial cells displayed a prominent degenerative profile (dentate gyrus > CA3 > CA1 > parahippocampal gyrus), including fragmented and dystrophic processes with spheroids, a reduced numerical density, and a significant decrease in the area of surveillance (“microglial domain”). Consequently, there was a substantial decline in the area covered by microglia which may compromise immune protection and, therefore, neuronal survival. In vitro experiments demonstrated that soluble fractions (extracellular/cytosolic) from AD hippocampi were toxic for microglial cells. This toxicity was abolished by AT8 and/or AT100 immunodepletion, validating that soluble phospho-tau was the toxic agent. These results were reproduced using soluble fractions from phospho-tau-positive Thy-tau22 hippocampi. Cultured microglial cells were not viable following phagocytosis of SH-SY5Y cells expressing soluble intracellular phospho-tau. Because the phagocytic capacity of microglial cells is highly induced by apoptotic signals in the affected neurons, we postulate that accumulation of intraneuronal soluble phospho-tau might trigger microglial degeneration in the AD hippocampus. This microglial vulnerability in AD pathology provides new insights into the immunological mechanisms underlying the disease progression and highlights the need to improve or develop new animal models, as the current models do not mimic the microglial pathology observed in the hippocampus of AD patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00401-016-1630-5) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2016-10-14 2016 /pmc/articles/PMC5106501/ /pubmed/27743026 http://dx.doi.org/10.1007/s00401-016-1630-5 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Paper
Sanchez-Mejias, Elisabeth
Navarro, Victoria
Jimenez, Sebastian
Sanchez-Mico, Maria
Sanchez-Varo, Raquel
Nuñez-Diaz, Cristina
Trujillo-Estrada, Laura
Davila, Jose Carlos
Vizuete, Marisa
Gutierrez, Antonia
Vitorica, Javier
Soluble phospho-tau from Alzheimer’s disease hippocampus drives microglial degeneration
title Soluble phospho-tau from Alzheimer’s disease hippocampus drives microglial degeneration
title_full Soluble phospho-tau from Alzheimer’s disease hippocampus drives microglial degeneration
title_fullStr Soluble phospho-tau from Alzheimer’s disease hippocampus drives microglial degeneration
title_full_unstemmed Soluble phospho-tau from Alzheimer’s disease hippocampus drives microglial degeneration
title_short Soluble phospho-tau from Alzheimer’s disease hippocampus drives microglial degeneration
title_sort soluble phospho-tau from alzheimer’s disease hippocampus drives microglial degeneration
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5106501/
https://www.ncbi.nlm.nih.gov/pubmed/27743026
http://dx.doi.org/10.1007/s00401-016-1630-5
work_keys_str_mv AT sanchezmejiaselisabeth solublephosphotaufromalzheimersdiseasehippocampusdrivesmicroglialdegeneration
AT navarrovictoria solublephosphotaufromalzheimersdiseasehippocampusdrivesmicroglialdegeneration
AT jimenezsebastian solublephosphotaufromalzheimersdiseasehippocampusdrivesmicroglialdegeneration
AT sanchezmicomaria solublephosphotaufromalzheimersdiseasehippocampusdrivesmicroglialdegeneration
AT sanchezvaroraquel solublephosphotaufromalzheimersdiseasehippocampusdrivesmicroglialdegeneration
AT nunezdiazcristina solublephosphotaufromalzheimersdiseasehippocampusdrivesmicroglialdegeneration
AT trujilloestradalaura solublephosphotaufromalzheimersdiseasehippocampusdrivesmicroglialdegeneration
AT davilajosecarlos solublephosphotaufromalzheimersdiseasehippocampusdrivesmicroglialdegeneration
AT vizuetemarisa solublephosphotaufromalzheimersdiseasehippocampusdrivesmicroglialdegeneration
AT gutierrezantonia solublephosphotaufromalzheimersdiseasehippocampusdrivesmicroglialdegeneration
AT vitoricajavier solublephosphotaufromalzheimersdiseasehippocampusdrivesmicroglialdegeneration